Pages that link to "Q44892463"
Jump to navigation
Jump to search
The following pages link to Economic costs of diabetes in the US in 2002. (Q44892463):
Displaying 50 items.
- "Metabolic" Surgery for Treatment of Type 2 Diabetes Mellitus (Q22241093) (← links)
- Bariatric Surgery in Patients with Type 2 Diabetes: A Viable Option (Q22241208) (← links)
- Economic costs of diabetes in the U.S. in 2012 (Q22241287) (← links)
- Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association (Q22241916) (← links)
- Epidemiologic and economic consequences of the global epidemics of obesity and diabetes (Q22251061) (← links)
- Sodium ferulate for preventing the progression of diabetic kidney disease (Q24236054) (← links)
- Individual patient education for people with type 2 diabetes mellitus (Q24240971) (← links)
- Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus (Q24548814) (← links)
- National trends in treatment of type 2 diabetes mellitus, 1994-2007 (Q24619979) (← links)
- The association between diabetes related medical costs and glycemic control: a retrospective analysis. (Q25255574) (← links)
- Toward prevention and control of type 2 diabetes: challenges at the U.S.-Mexico border and beyond (Q25255622) (← links)
- Diabetes and Mexicans: why the two are linked (Q25255644) (← links)
- Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples (Q26774170) (← links)
- Glucose control in diabetes: the impact of racial differences on monitoring and outcomes (Q26828633) (← links)
- Economic burden of torture for a refugee host country: development of a model and presentation of a country case study (Q27022337) (← links)
- Dynamic -Helix Structure of Micelle-bound Human Amylin (Q27653951) (← links)
- Community Interventions to Improve Glycemic Control in African Americans with Type 2 Diabetes: A Systemic Review (Q28086944) (← links)
- The Economic Costs of Type 2 Diabetes: A Global Systematic Review (Q28087120) (← links)
- Development and clinical outcomes of pharmacist-managed diabetes care clinics (Q28198658) (← links)
- The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients (Q28201491) (← links)
- Molecular mechanisms of chromium in alleviating insulin resistance (Q28262068) (← links)
- A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine (Q29547303) (← links)
- Blood pressure lowering for the prevention and treatment of diabetic kidney disease. (Q30358393) (← links)
- Cost of diabetes care in out-patient clinics of Karachi, Pakistan (Q30481071) (← links)
- Type 2 diabetes risk forecasting from EMR data using machine learning. (Q30585462) (← links)
- An informatics approach to medication adherence assessment and improvement using clinical, billing, and patient-entered data. (Q30670604) (← links)
- The Cost of Managing Type 2 Diabetes Mellitus in Greece: A Retrospective Analysis of 10-Year Patient Level Data "The HERCULES Study". (Q30975091) (← links)
- Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials (Q30975622) (← links)
- Racial/Ethnic and social class differences in preventive care practices among persons with diabetes (Q33260936) (← links)
- Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001 (Q33266312) (← links)
- Predictors of health-related quality of life in type II diabetic patients in Greece (Q33292478) (← links)
- Health care utilization and costs in Saskatchewan's registered Indian population with diabetes (Q33294094) (← links)
- Diversity in diabetes care programmes and views on high quality diabetes care: are we in need of a standardized framework? (Q33336554) (← links)
- Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study (Q33393473) (← links)
- Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis (Q33398039) (← links)
- Diabetic retinopathy: current management and experimental therapeutic targets. (Q33403016) (← links)
- Primary treatment of diabetic macular edema (Q33463319) (← links)
- Brief report: normative data on a structured interview for diabetes adherence in childhood (Q33480448) (← links)
- Examining the economic costs related to lifestyle and pharmacological interventions in youth with Type 2 diabetes (Q33506099) (← links)
- Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis (Q33534641) (← links)
- Diabetic neuropathy: mechanisms to management (Q33554384) (← links)
- Chemometric assessment of clinical data for diabetes mellitus 2 type patients using self-organizing maps (Q33555300) (← links)
- Healthcare costs associated with progressive diabetic retinopathy among National Health Insurance enrollees in Taiwan, 2000-2004. (Q33586935) (← links)
- Changes in ideal cardiovascular health status and risk of new-onset type 2 diabetes: The Kailuan prospective study (Q33590543) (← links)
- Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk (Q33602120) (← links)
- Association between cognitive function and social support with glycemic control in adults with diabetes mellitus (Q33605780) (← links)
- Simulating and evaluating local interventions to improve cardiovascular health (Q33611019) (← links)
- Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women (Q33619705) (← links)
- Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method (Q33634067) (← links)
- Vigorous exercise and diabetic, hypertensive, and hypercholesterolemia medication use. (Q33639162) (← links)